Bayer
Global Awards wins for Langland
November 25, 2009Medical Communications Bayer, Langland, Pfizer, awards, counterfeits, get real
Windsor-based advertising agency Langland has won three trophies at the prestigious Global Awards for healthcare communications.Two of these were for …
Digital Pharma: Bayer brings the InBed Dr to YouTube
October 22, 2009Medical Communications Bayer, digi, digital pharma, digital pharma YouTube
Bayer Schering Pharma has expanded its InBed erectile dysfunction awareness campaign, adding to YouTube 60 short videos that take a …
FDA warns Bayer over German API facility
September 17, 2009Manufacturing and Production Bayer, FDA, reg
The US regulator has sent a warning letter to Bayer indicating it found "significant deviations from US current good manufacturing …
Bayer has solution for solvent shortage in pharma
August 4, 2009Manufacturing and Production Bayer
German chemical company Bayer says it could have a solution to help ease the current shortage of acetonitrile, a solvent …
Bayer to launch OTC omeprazole in Germany
July 17, 2009Sales and Marketing Bayer, OTC
Bayer Vital, the marketing arm of Bayer HealthCare, is to launch the proton pump inhibitor omeprazole as an over-the-counter heartburn …
Bayer signs deal with Celera on cancer targets
June 30, 2009Research and Development, Sales and Marketing Bayer, Celera
Bayer Schering Pharma has signed a deal with Celera to give it access to five cancer-related targets for therapeutic development …
Genzyme buys rights to Bayer MS candidate
June 4, 2009Sales and Marketing Bayer, Genzyme
Genzyme has bought the global rights multiple sclerosis (MS) candidate Campath/MabCampath from Bayer HealthCare.Originally discovered by Genzyme, Campath (alemtuzumab) is …
NICE rejects Nexavar for liver cancer
May 7, 2009Research and Development, Sales and Marketing Bayer, NICE, Nexavar
NICE has rejected Nexavar as a treatment for liver cancer, saying it is not a cost-effective use of NHS resources. …
Bayer launches UK television ads for its morning-after pill
May 6, 2009Sales and Marketing Bayer
Bayer Schering Pharma has launched a television advertising campaign for its morning-after pill Levonelle One Step in the UK. The …
Bayer Schering’s contraceptive patch enters phase III
May 5, 2009Research and Development, Sales and Marketing Bayer, sexual health
Bayer Schering is to start phase III trials of its new contraceptive patch and anticipates submitting the product for regulatory …
Nexavar fails in melanoma study
April 30, 2009Research and Development Bayer, Cancer, Nexavar
Onyx Pharmaceuticals and its development partner Bayer have stopped a phase II trial of Nexavar in patients with late-stage melanoma, …
NICE approves Bayer’s Xarelto
April 23, 2009Research and Development Bayer, NICE, Xarelto
NICE has approved Bayer's anti-clotting treatment Xarelto, bringing it into line with Boehringer Ingelheim's rival Pradaxa. Xarelto (rivaroxaban) was assessed …
Bayer Schering Pharma restricts UK distribution
April 2, 2009Manufacturing and Production Bayer
Bayer Schering Pharma has joined the ranks of firms switching to restrictive distribution arrangements in the UK. The pharma company, …
Bayer strikes R&D deal with Chinese university
March 20, 2009Research and Development Bayer, China, academic research
Bayer has furthered its R&D expansion in China with an agreement to form a joint pharmaceutical research centre with Tsinghua …
Latest content
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical
